Please enable JavaScript to continue using this application.

Compare $AGIO vs $VCEL | Chartloom

Compare

$AGIO vs $VCEL

Agios Pharmaceuticals Inc · Vericel Corp

AGIO

Agios Pharmaceuticals Inc

VCEL

Vericel Corp

Compare $AGIO vs $VCEL

Comparing Agios Pharmaceuticals Inc and Vericel Corp

AGIOAgios Pharmaceuticals Inc

VCELVericel Corp

AGIOAgios Pharmaceuticals Inc

Market cap

$1.89B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.91x

Rev growth (TTM)

140.6%

YTD performance

17.0%

52W performance

-25.3%

FCF yield

-19.3%

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGIO

VCEL

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

VCEL

Vericel Corp

Market Cap

AGIO$1.89B

VCEL$2.05B

Enterprise Value

AGIO$1.79B

VCEL$1.92B

Price

AGIO$31.81

VCEL$40.10

P/E Ratio

AGION/A

VCEL86.61x

P/S Ratio

AGIO19.24x

VCEL6.69x

EV/Sales

AGIO18.22x

VCEL6.28x

EV/EBITDA

AGIO2.84x

VCEL58.45x

P/B Ratio

AGIO1.85x

VCEL5.56x

P/FCF Ratio

AGION/A

VCEL33.21x

EV/FCF

AGIO-4.91x

VCEL31.19x

PEG Ratio

AGION/A

VCEL0.32x

Forward P/E (NTM)

AGION/A

VCEL55.49x

Forward P/S (NTM)

AGIO6.91x

VCEL5.56x

Revenue (TTM)

AGIO$98M

VCEL$306M

Revenue Growth (YoY)

AGIO140.6%

VCEL23.0%

Forward Rev Growth

AGIO92.6%

VCEL16.9%

Gross Margin (TTM)

AGIO92.0%

VCEL74.6%

Operating Margin (TTM)

AGIO0.0%

VCEL6.0%

EBITDA Margin (TTM)

AGIO-461.3%

VCEL10.2%

Net Margin (TTM)

AGIO-418.2%

VCEL7.9%

FCF Margin (TTM)

AGIO-371.4%

VCEL20.1%

Net Income (TTM)

AGIO$-411M

VCEL$24M

FCF (TTM)

AGIO$-365M

VCEL$62M

EPS (TTM)

AGIO-$6.91

VCEL$0.46

ROE (TTM)

AGIO-3567.0%

VCEL6.9%

ROA (TTM)

AGIO-3306.0%

VCEL5.0%

ROIC (TTM)

AGIO-3567.0%

VCEL6.9%

Cash

AGIO$100M

VCEL$125M

Debt

AGIO$0

VCEL$596K

Net Cash/Debt

AGIO$100M

VCEL$125M

Current Ratio (TTM)

AGIO10.22x

VCEL5.04x

Quick Ratio (TTM)

AGIO9.14x

VCEL4.69x

Debt/Equity (TTM)

AGIO0.00x

VCEL0.00x

Debt/Assets (TTM)

AGIO0.0%

VCEL0.0%

Interest Coverage (TTM)

AGION/A

VCELN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

VCEL0.00x

Beta

AGIO0.62

VCEL1.06

52W Performance

AGIO-25.3%

VCEL17.5%

YTD Performance

AGIO17.0%

VCEL12.6%

% from 52W High

AGIO-30.8%

VCEL-18.7%

% from 52W Low

AGIO43.0%

VCEL38.5%

Asset Turnover (TTM)

AGIO0.08x

VCEL0.63x

FCF Yield (TTM)

AGIO-19.3%

VCEL3.0%

Earnings Yield (TTM)

AGIO-21.7%

VCEL1.2%

Dividend Yield (TTM)

AGION/A

VCELN/A

Rule of 40

AGIO-230.8

VCEL43.1

EV/GP/RG

AGIO0.06

VCEL0.39

Ticker research

View AGIO research View VCEL research

Metric	AGIO Agios Pharmaceuticals Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.89B	$2.05B
Enterprise Value	$1.79B	$1.92B
Price	$31.81	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	19.24x	6.69x
EV/Sales	18.22x	6.28x
EV/EBITDA	2.84x	58.45x
P/B Ratio	1.85x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-4.91x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	6.91x	5.56x
Revenue & Growth
Revenue (TTM)	$98M	$306M
Revenue Growth (YoY)	140.6%	23.0%
Forward Rev Growth	92.6%	16.9%
Profitability
Gross Margin (TTM)	92.0%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	-461.3%	10.2%
Net Margin (TTM)	-418.2%	7.9%
FCF Margin (TTM)	-371.4%	20.1%
Net Income (TTM)	$-411M	$24M
FCF (TTM)	$-365M	$62M
EPS (TTM)	-$6.91	$0.46
ROE (TTM)	-3567.0%	6.9%
ROA (TTM)	-3306.0%	5.0%
ROIC (TTM)	-3567.0%	6.9%
Financial Health
Cash	$100M	$125M
Debt	$0	$596K
Net Cash/Debt	$100M	$125M
Current Ratio (TTM)	10.22x	5.04x
Quick Ratio (TTM)	9.14x	4.69x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.06
52W Performance	-25.3%	17.5%
YTD Performance	17.0%	12.6%
% from 52W High	-30.8%	-18.7%
% from 52W Low	43.0%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.63x
FCF Yield (TTM)	-19.3%	3.0%
Earnings Yield (TTM)	-21.7%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	43.1
EV/GP/RG	0.06	0.39
Ticker research	View AGIO research	View VCEL research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

VCEL

6.69x

AGIO

19.24x

EV/FCF

AGIO

-4.91x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

AGIO

140.6%

VCEL

23.0%

Forward Revenue Growth

AGIO

92.6%

VCEL

16.9%

Profitability & performance

Gross Margin

AGIO

92.0%

VCEL

74.6%

ROE

VCEL

6.9%

AGIO

-3567.0%

FCF Yield %

VCEL

3.0%

AGIO

-19.3%

52-Week Performance

VCEL

17.5%

AGIO

-25.3%

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

VCEL

Vericel Corp

Market Cap

AGIO$1.89B

VCEL$2.05B

Enterprise Value

AGIO$1.79B

VCEL$1.92B

Price

AGIO$31.81

VCEL$40.10

P/E Ratio

AGION/A

VCEL86.61x

P/S Ratio

AGIO19.24x

VCEL6.69x

EV/Sales

AGIO18.22x

VCEL6.28x

EV/EBITDA

AGIO2.84x

VCEL58.45x

P/B Ratio

AGIO1.85x

VCEL5.56x

P/FCF Ratio

AGION/A

VCEL33.21x

EV/FCF

AGIO-4.91x

VCEL31.19x

PEG Ratio

AGION/A

VCEL0.32x

Forward P/E (NTM)

AGION/A

VCEL55.49x

Forward P/S (NTM)

AGIO6.91x

VCEL5.56x

Revenue (TTM)

AGIO$98M

VCEL$306M

Revenue Growth (YoY)

AGIO140.6%

VCEL23.0%

Forward Rev Growth

AGIO92.6%

VCEL16.9%

Gross Margin (TTM)

AGIO92.0%

VCEL74.6%

Operating Margin (TTM)

AGIO0.0%

VCEL6.0%

EBITDA Margin (TTM)

AGIO-461.3%

VCEL10.2%

Net Margin (TTM)

AGIO-418.2%

VCEL7.9%

FCF Margin (TTM)

AGIO-371.4%

VCEL20.1%

Net Income (TTM)

AGIO$-411M

VCEL$24M

FCF (TTM)

AGIO$-365M

VCEL$62M

EPS (TTM)

AGIO-$6.91

VCEL$0.46

ROE (TTM)

AGIO-3567.0%

VCEL6.9%

ROA (TTM)

AGIO-3306.0%

VCEL5.0%

ROIC (TTM)

AGIO-3567.0%

VCEL6.9%

Cash

AGIO$100M

VCEL$125M

Debt

AGIO$0

VCEL$596K

Net Cash/Debt

AGIO$100M

VCEL$125M

Current Ratio (TTM)

AGIO10.22x

VCEL5.04x

Quick Ratio (TTM)

AGIO9.14x

VCEL4.69x

Debt/Equity (TTM)

AGIO0.00x

VCEL0.00x

Debt/Assets (TTM)

AGIO0.0%

VCEL0.0%

Interest Coverage (TTM)

AGION/A

VCELN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

VCEL0.00x

Beta

AGIO0.62

VCEL1.06

52W Performance

AGIO-25.3%

VCEL17.5%

YTD Performance

AGIO17.0%

VCEL12.6%

% from 52W High

AGIO-30.8%

VCEL-18.7%

% from 52W Low

AGIO43.0%

VCEL38.5%

Asset Turnover (TTM)

AGIO0.08x

VCEL0.63x

FCF Yield (TTM)

AGIO-19.3%

VCEL3.0%

Earnings Yield (TTM)

AGIO-21.7%

VCEL1.2%

Dividend Yield (TTM)

AGION/A

VCELN/A

Rule of 40

AGIO-230.8

VCEL43.1

EV/GP/RG

AGIO0.06

VCEL0.39

Ticker research

View AGIO research View VCEL research

Metric	AGIO Agios Pharmaceuticals Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.89B	$2.05B
Enterprise Value	$1.79B	$1.92B
Price	$31.81	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	19.24x	6.69x
EV/Sales	18.22x	6.28x
EV/EBITDA	2.84x	58.45x
P/B Ratio	1.85x	5.56x
P/FCF Ratio	N/A	33.21x
EV/FCF	-4.91x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	N/A	55.49x
Forward P/S (NTM)	6.91x	5.56x
Revenue & Growth
Revenue (TTM)	$98M	$306M
Revenue Growth (YoY)	140.6%	23.0%
Forward Rev Growth	92.6%	16.9%
Profitability
Gross Margin (TTM)	92.0%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	-461.3%	10.2%
Net Margin (TTM)	-418.2%	7.9%
FCF Margin (TTM)	-371.4%	20.1%
Net Income (TTM)	$-411M	$24M
FCF (TTM)	$-365M	$62M
EPS (TTM)	-$6.91	$0.46
ROE (TTM)	-3567.0%	6.9%
ROA (TTM)	-3306.0%	5.0%
ROIC (TTM)	-3567.0%	6.9%
Financial Health
Cash	$100M	$125M
Debt	$0	$596K
Net Cash/Debt	$100M	$125M
Current Ratio (TTM)	10.22x	5.04x
Quick Ratio (TTM)	9.14x	4.69x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.06
52W Performance	-25.3%	17.5%
YTD Performance	17.0%	12.6%
% from 52W High	-30.8%	-18.7%
% from 52W Low	43.0%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.63x
FCF Yield (TTM)	-19.3%	3.0%
Earnings Yield (TTM)	-21.7%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	43.1
EV/GP/RG	0.06	0.39
Ticker research	View AGIO research	View VCEL research